MARK F PELSTRING
Allopathic & Osteopathic Physicians|Family Medicine LORIS, SC NPI 1285726232
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine SC Novo Nordisk AS All categories
General Payments — all program years on this page
$2,379.09
- Category: General Payments
- Program years: PY2018–2022
- Record count: 161
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $112.73 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $112.73 | 7 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $31.66 | 2 |
| Abbott Laboratories | $18.54 | 1 |
| Amarin Pharma Inc. | $18.12 | 1 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | $17.75 | 1 |
| ABBVIE INC. | $13.84 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $12.82 | 1 |
By program year
Records — PY2022 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 891347221 | ABBVIE INC. | $13.84 | 02/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 902742887 | Novo Nordisk Inc | $14.03 | 02/08/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 902755227 | Novo Nordisk Inc | $17.63 | 01/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 913916887 | Amarin Pharma Inc. | $18.12 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 914175483 | Abbott Laboratories | $18.54 | 07/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 923698729 | Biohaven Pharmaceutical Holding Company Ltd. | $17.75 | 01/19/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 929936221 | Bayer HealthCare Pharmaceuticals Inc. | $12.82 | 01/24/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.